| Product Code: ETC6416728 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bhutan Deep Vein Thrombosis Market Overview |
3.1 Bhutan Country Macro Economic Indicators |
3.2 Bhutan Deep Vein Thrombosis Market Revenues & Volume, 2021 & 2031F |
3.3 Bhutan Deep Vein Thrombosis Market - Industry Life Cycle |
3.4 Bhutan Deep Vein Thrombosis Market - Porter's Five Forces |
3.5 Bhutan Deep Vein Thrombosis Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Bhutan Deep Vein Thrombosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about deep vein thrombosis (DVT) and its risks among the Bhutanese population |
4.2.2 Growing adoption of advanced diagnostic technologies for early detection of DVT |
4.2.3 Rise in the aging population in Bhutan leading to a higher prevalence of DVT |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities and expertise for diagnosing and treating DVT in Bhutan |
4.3.2 High cost associated with DVT treatment and management in the country |
5 Bhutan Deep Vein Thrombosis Market Trends |
6 Bhutan Deep Vein Thrombosis Market, By Types |
6.1 Bhutan Deep Vein Thrombosis Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Bhutan Deep Vein Thrombosis Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Bhutan Deep Vein Thrombosis Market Revenues & Volume, By Arixtra (Fondaparinux sodium), 2021- 2031F |
6.1.4 Bhutan Deep Vein Thrombosis Market Revenues & Volume, By Fragmin (Dalteparin sodium), 2021- 2031F |
6.1.5 Bhutan Deep Vein Thrombosis Market Revenues & Volume, By Eliquis (Apixaban), 2021- 2031F |
6.1.6 Bhutan Deep Vein Thrombosis Market Revenues & Volume, By Savaysa (Edoxaban), 2021- 2031F |
6.1.7 Bhutan Deep Vein Thrombosis Market Revenues & Volume, By Xarelto (Rivaroxaban), 2021- 2031F |
6.1.8 Bhutan Deep Vein Thrombosis Market Revenues & Volume, By Abelacimab, 2021- 2031F |
7 Bhutan Deep Vein Thrombosis Market Import-Export Trade Statistics |
7.1 Bhutan Deep Vein Thrombosis Market Export to Major Countries |
7.2 Bhutan Deep Vein Thrombosis Market Imports from Major Countries |
8 Bhutan Deep Vein Thrombosis Market Key Performance Indicators |
8.1 Number of DVT awareness campaigns conducted in Bhutan |
8.2 Percentage increase in the adoption of advanced diagnostic technologies for DVT in Bhutan |
8.3 Average age of individuals diagnosed with DVT in Bhutan |
8.4 Accessibility index of specialized healthcare facilities for DVT treatment in Bhutan |
8.5 Average out-of-pocket healthcare expenditure for DVT management in Bhutan |
9 Bhutan Deep Vein Thrombosis Market - Opportunity Assessment |
9.1 Bhutan Deep Vein Thrombosis Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Bhutan Deep Vein Thrombosis Market - Competitive Landscape |
10.1 Bhutan Deep Vein Thrombosis Market Revenue Share, By Companies, 2024 |
10.2 Bhutan Deep Vein Thrombosis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |